| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
The Urologic Laboratory, Department of Urology [L. Z., J. L., M. R. F.], and the Department of Orthopaedic Surgery, Childrens Hospital [K. R. S.], Division of Urologic Surgery, Brigham and Womens Hospital [M. L. L.], and the Department of Surgery, Harvard Medical School [L. Z., J. L., M. L. L., K. R. S., M. R. F.], Boston, Massachusetts 02115
Although cholesterol accumulation in tumors was first reported in the early20th century, the mechanistic implications of this observation are stillobscure. Here we report that caveolin-negative human prostate cancer (LNCaP) cells contain cholesterol-rich lipid rafts that mediate epidermal growth factor (EGF)-induced and constitutive signaling through the Akt1 serine-threonine kinase. EGF receptor and Akt1 phosphorylation were inhibited and autonomous cell survival was reduced when the rafts were disrupted. Reconstitution of the rafts with cholesterol restored EGF receptor
Akt1 axis signaling and cytoprotection from a phosphoinositide 3-kinase-dependent apoptotic signal. These results suggest that cholesterol present in membrane microdomains is a prominent mediator of survival in prostate cancer cells.
This article has been cited by other articles:
![]() |
C. M. Klinge, N. S. Wickramasinghe, M. M. Ivanova, and S. M. Dougherty Resveratrol stimulates nitric oxide production by increasing estrogen receptor {alpha}-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells FASEB J, July 1, 2008; 22(7): 2185 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Chinni, H. Yamamoto, Z. Dong, A. Sabbota, R. D. Bonfil, and M. L. Cher CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone Mol. Cancer Res., March 1, 2008; 6(3): 446 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Farwell, R. E. Scranton, E. V. Lawler, R. A. Lew, M. T. Brophy, L. D. Fiore, and J. M. Gaziano The Association Between Statins and Cancer Incidence in a Veterans Population J Natl Cancer Inst, January 16, 2008; 100(2): 134 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Flick, L. A. Habel, K. A. Chan, S. K. Van Den Eeden, V. P. Quinn, R. Haque, E. J. Orav, J. D. Seeger, M. C. Sadler, C. P. Quesenberry Jr., et al. Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2218 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cinar, N. K. Mukhopadhyay, G. Meng, and M. R. Freeman Phosphoinositide 3-Kinase-independent Non-genomic Signals Transit from the Androgen Receptor to Akt1 in Membrane Raft Microdomains J. Biol. Chem., October 5, 2007; 282(40): 29584 - 29593. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Campbell, N. A. Louis, S. E. Tomassetti, G. O. Canny, M. Arita, C. N. Serhan, and S. P. Colgan Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution FASEB J, October 1, 2007; 21(12): 3162 - 3170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jagla, M. Feve, P. Kessler, G. Lapouge, E. Erdmann, S. Serra, J.-P. Bergerat, and J. Ceraline A Splicing Variant of the Androgen Receptor Detected in a Metastatic Prostate Cancer Exhibits Exclusively Cytoplasmic Actions Endocrinology, September 1, 2007; 148(9): 4334 - 4343. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Sun, C. R. Weber, A. Sohail, M. M. Bernardo, M. Toth, H. Zhao, J. R. Turner, and R. Fridman MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties J. Biol. Chem., July 27, 2007; 282(30): 21998 - 22010. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Adam, N. K. Mukhopadhyay, J. Kim, D. Di Vizio, B. Cinar, K. Boucher, K. R. Solomon, and M. R. Freeman Cholesterol Sensitivity of Endogenous and Myristoylated Akt Cancer Res., July 1, 2007; 67(13): 6238 - 6246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi, T. Nagao, H. I. Ingolfsson, F. R. Maxfield, O. S. Andersen, L. Kopelovich, and I. B. Weinstein The Inhibitory Effect of (-)-Epigallocatechin Gallate on Activation of the Epidermal Growth Factor Receptor Is Associated with Altered Lipid Order in HT29 Colon Cancer Cells Cancer Res., July 1, 2007; 67(13): 6493 - 6501. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Platz, M. F. Leitzmann, K. Visvanathan, E. B. Rimm, M. J. Stampfer, W. C. Willett, and E. Giovannucci Statin Drugs and Risk of Advanced Prostate Cancer J Natl Cancer Inst, December 20, 2006; 98(24): 1819 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. D. Landry, M. Denis, S. Nandi, S. Bell, A. M. Vaughan, and X. Zha ATP-binding Cassette Transporter A1 Expression Disrupts Raft Membrane Microdomains through Its ATPase-related Functions J. Biol. Chem., November 24, 2006; 281(47): 36091 - 36101. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Li, M. J. Park, S.-K. Ye, C.-W. Kim, and Y.-N. Kim Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents Am. J. Pathol., April 1, 2006; 168(4): 1107 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sachdev, R. Singh, Y. Fujita-Yamaguchi, and D. Yee Down-regulation of Insulin Receptor by Antibodies against the Type I Insulin-Like Growth Factor Receptor: Implications for Anti-Insulin-Like Growth Factor Therapy in Breast Cancer Cancer Res., February 15, 2006; 66(4): 2391 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Matthews, M. J. Taggart, and M. Westwood Effect of Cholesterol Depletion on Mitogenesis and Survival: The Role of Caveolar and Noncaveolar Domains in Insulin-Like Growth Factor-Mediated Cellular Function Endocrinology, December 1, 2005; 146(12): 5463 - 5473. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Urs, K. T. Jones, P. D. Salo, J. E. Severin, J. Trejo, and H. Radhakrishna A requirement for membrane cholesterol in the {beta}-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors J. Cell Sci., November 15, 2005; 118(22): 5291 - 5304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shannon, S. Tewoderos, M. Garzotto, T. M. Beer, R. Derenick, A. Palma, and P. E. Farris Statins and Prostate Cancer Risk: A Case-Control Study Am. J. Epidemiol., August 15, 2005; 162(4): 318 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mannova and L. Beretta Activation of the N-Ras-PI3K-Akt-mTOR Pathway by Hepatitis C Virus: Control of Cell Survival and Viral Replication J. Virol., July 15, 2005; 79(14): 8742 - 8749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Alessio, R. S. Al-Lamki, J. R. Bradley, and J. S. Pober Caveolae Participate in Tumor Necrosis Factor Receptor 1 Signaling and Internalization in a Human Endothelial Cell Line Am. J. Pathol., April 1, 2005; 166(4): 1273 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Redfern and A. Gericke pH-dependent domain formation in phosphatidylinositol polyphosphate/phosphatidylcholine mixed vesicles J. Lipid Res., March 1, 2005; 46(3): 504 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fukuchi, R. A. Hiipakka, J. M. Kokontis, S. Hsu, A. L. Ko, M. L. Fitzgerald, and S. Liao Androgenic Suppression of ATP-binding Cassette Transporter A1 Expression in LNCaP Human Prostate Cancer Cells Cancer Res., November 1, 2004; 64(21): 7682 - 7685. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Maeda, S. Nagata, C. D. Wolfgang, G. L. Bratthauer, T. K. Bera, and I. Pastan The T Cell Receptor {gamma} Chain Alternate Reading Frame Protein (TARP), a Prostate-specific Protein Localized in Mitochondria J. Biol. Chem., June 4, 2004; 279(23): 24561 - 24568. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Redfern and A. Gericke Domain Formation in Phosphatidylinositol Monophosphate/Phosphatidylcholine Mixed Vesicles Biophys. J., May 1, 2004; 86(5): 2980 - 2992. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, R. M. Adam, K. R. Solomon, and M. R. Freeman Involvement of Cholesterol-Rich Lipid Rafts in Interleukin-6-Induced Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells Endocrinology, February 1, 2004; 145(2): 613 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Assa-Kunik, D. Fishman, S. Kellman-Pressman, S. Tsory, S. Elhyany, O. Baharir, and S. Segal Alterations in the Expression of MHC Class I Glycoproteins by B16BL6 Melanoma Cells Modulate Insulin Receptor-Regulated Signal Transduction and Augments Resistance to Apoptosis J. Immunol., September 15, 2003; 171(6): 2945 - 2952. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |